Navigation Links
Sigma-Aldrich (Nasdaq: SIAL) Announces Executive Management Changes: Retirement of David Julien and Promotion of Joseph Porwoll
Date:5/14/2010

ST. LOUIS, May 14 /PRNewswire-FirstCall/ -- Sigma-Aldrich announces the retirement of David Julien, President – Global Supply Chain effective on June 30, 2010.  Mr. Julien took on his current role in January 2009.  He served as President of the Research Specialties unit of the Company from July 2005 to January 2009 and before that in a number of senior roles including that of President of the Research Biotech unit of the Company.

(Logo:  http://www.newscom.com/cgi-bin/prnh/20050215/CGSIGMAALLOGO)

The Company is pleased to announce that Joseph Porwoll has been promoted to Vice President, Global Supply Chain and will take over the responsibilities held by Mr. Julien.  Mr. Porwoll holds a PhD in chemistry from the University of Minnesota and has been with the Company for 26 years in roles of increasing responsibility, most recently as Vice President of the Company's Wisconsin-based operations.

President and CEO Jai Nagarkatti commented, "We thank Dave Julien for his tremendous leadership and contributions over the years.  He played an integral role in making our Company a global player in the life sciences industry.  While we are sad to see Dave leave us and wish him well in his retirement, we are pleased to add Joe Porwoll to our executive team.  Joe is a strong manager with substantial experience and skill in manufacturing, distribution, procurement and planning functions.  This internal promotion is indicative of the commitment we have to developing talent at Sigma-Aldrich.  Joe is expected to build upon Dave's work in streamlining our global supply chain creating a competitive advantage by enhancing service and thereby enabling our customers' success."

About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company. Our biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing. We have customers in life science companies, university and government institutions, hospitals and in industry. Over one million scientists and technologists use our products. Sigma-Aldrich operates in 38 countries and has 7,600 employees providing excellent service worldwide. We are committed to Accelerating our Customers' Success through Innovation and Leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit our award winning web site at http://www.sigma-aldrich.com


'/>"/>
SOURCE Sigma-Aldrich
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Sigma-Aldrich (Nasdaq: SIAL) Declares Quarterly Dividend
2. Sigma-Aldrich and Lab Manager Magazine Present Webinar On Laboratory Environmental, Health and Safety Compliance Strategies
3. Sigma-Aldrich Expansion in Republic of China to Support SAFC Growth
4. Sigma-Aldrich and Ingenuity Systems Announce Partnership to Create E-Commerce Search Solution Based on Biological Knowledge
5. Sigma-Aldrich to Present at the UBS 2007 Global Life Sciences Conference on September 25, 2007
6. Sigma-Aldrich Names Patrick Sullivan New VP of Research and Development for Research Biotech
7. Sigma-Aldrich and the Universite de Montreal Establish Collaboration for RNA Interference Studies
8. Sigma-Aldrich Corporations 3rd Quarter 2007 Earnings Conference Call
9. Sigma-Aldrich Introduces N-TER Nanoparticle siRNA Transfection System for Delivery of siRNA Into Difficult-to-Transfect Cell Types
10. Sigma-Aldrich (Nasdaq: SIAL) Q3 2007 Sales Increase 14.0%, Yielding Diluted EPS of $.54.
11. Sigma-Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2017)... ... July 13, 2017 , ... Trinity Sterile, Inc., ... medical supplies has chosen The Copley Consulting Group to implement and deploy the ... align its internal and backend operations to streamline efficiencies to meet the increasing ...
(Date:7/12/2017)... ... July 12, 2017 , ... Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), ... used for diagnostic tests, announced today that its initial public offering of 1,178,532 shares ... the offering will be $7,071,192. , The shares will begin trading on July 12, ...
(Date:7/12/2017)... CA (PRWEB) , ... July 12, 2017 , ... Dr. ... is the most recent recipient of a Microbiome Impact Grant from uBiome, the leading ... role of the skin microbiome in the transmission of pathogens between elderly people in ...
(Date:7/12/2017)... , ... July 12, 2017 , ... Exact Diagnostics continues ... for In Vitro Diagnostic (IVD) use. Panels available include: Adenovirus, BKV, ... , The Exact Diagnostics Verification Panels may be used as calibrators to establish ...
Breaking Biology Technology:
(Date:6/14/2017)... , June 15, 2017  IBM (NYSE: IBM ) is ... tech event dedicated to developing collaboration between startups and global ... June 15-17. During the event, nine startups will showcase the ... in various industries. France ... international market, with a 30 percent increase in the number ...
(Date:5/16/2017)... --  Bridge Patient Portal , an enterprise patient ... Systems , an electronic medical record solutions developer ... a partnership to build an interface between the ... products, including Centricity Practice Solution (CPS), Centricity Business ... integrations will allow healthcare delivery networks using GE ...
(Date:4/19/2017)... ALBANY, New York , April 19, 2017 /PRNewswire/ ... highly competitive, as its vendor landscape is marked by ... in the market is however held by five major ... and Safran. Together these companies accounted for nearly 61% ... majority of the leading companies in the global military ...
Breaking Biology News(10 mins):